MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and Other Chronic Diseases

Major histocompatibility complex–associated peptides have been considered as potential immunotherapeutic targets for many years. MHC class I phosphopeptides result from dysregulated cell signaling pathways that are common across cancers and both viral and bacterial infections. These antigens are rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahoney, Keira E., Shabanowitz, Jeffrey, Hunt, Donald F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724925/
https://www.ncbi.nlm.nih.gov/pubmed/34129940
http://dx.doi.org/10.1016/j.mcpro.2021.100112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724925/
https://www.ncbi.nlm.nih.gov/pubmed/34129940
http://dx.doi.org/10.1016/j.mcpro.2021.100112

Ejemplares similares